A new ADHD App InFlow can help people suffering from attention deficit hyperactivity disorder or ADHD. It does so using cognitive behavioral therapy CBT techniques. The ADHD app Inflow just raised $2.3 million in seed funding in a round led by London-based Hoxton Ventures.
Founded in 2020 by Seb Isaacs and Levi Epstein, the InFlow ADHD app previously brought in $680,000. Inflow says that its app was designed by people with ADHD, and that it is a science-based digital program.
The Inflow ADHD app is based on the principles of CBT, which the company says is proven to be effective in the management of ADHD.
According to the CDC, ADHD is one of the most common neurodevelopmental disorders of childhood. It is usually first diagnosed and often lasts into adulthood. Children with ADHD may have trouble paying attention, controlling impulsive behaviors (may act without thinking about what the result will be), or be overly active.
It is normal for children to have trouble focusing and behaving at one time or another. However, children with ADHD do not just grow out of these behaviors. The symptoms continue, can be severe, and can cause difficulty at school, at home, or with friends.
The Mayo Clinic explains that cognitive behavioral therapy is a common type of talk therapy (psychotherapy). A person works with a mental health counselor (psychotherapist or therapist) in a structured way, attending a limited number of sessions. CBT helps the person become aware of inaccurate or negative thinking so you can view challenging situations more clearly and respond to them in a more effective way.
Misconceptions that neurotypicals might have about their ADHD Colleagues vs. The Reality
♿ (ALT text provided)
— Inflow: ADHD app 🧠📱 (@get_inflow) January 15, 2022
Seb Isaacs said, “We knew we could simplify the ADHD care process and reach millions of underserved people living with ADHD. Inflow can offer immediate, affordable, and on-demand support in ways our burdened mental health system simply cannot. There’s no waitlist, no need for a referral, no complicated intake process.”